Dusek L - Search Results

1

International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.

Scudla V, Zemanova M, Minarik J, Bacovsky J, Ordeltova M, Indrak K, Budikova M, Dusek L, Farbiakova V. Scudla V, et al. Among authors: dusek l. Neoplasma. 2006;53(4):277-84. Neoplasma. 2006. PMID: 16830053

2

Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.

Scudla V, Ordeltova M, Minarik J, Dusek L, Zemanova M, Bacovsky J. Scudla V, et al. Among authors: dusek l. Neoplasma. 2006;53(3):213-8. Neoplasma. 2006. PMID: 16652190

3

Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CT.

Papajik T, Myslivecek M, Skopalova M, Malan A, Buriankova E, Koza V, Hnatkova M, Trneny M, Sedova Z, Kubova Z, Koranda P, Flodr P, Jarkovsky J, Dusek L, Indrak K. Papajik T, et al. Among authors: dusek l. Neoplasma. 2011;58(4):291-7. doi: 10.4149/neo_2011_04_291. Neoplasma. 2011. PMID: 21524147

4

Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT).

Doubek M, Muzík J, Szotkowski T, Koza V, Cetkovský P, Kozák T, Zák P, Voglová J, Struncová S, Dusek L, Indrák K. Doubek M, et al. Among authors: dusek l. Neoplasma. 2007;54(1):89-94. Neoplasma. 2007. PMID: 17233551

5

High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.

Papajik T, Raida L, Faber E, Vondrakova J, Prochazka V, Kubova Z, Skoumalova I, Jarosova M, M LK, Paucek B, Myslivecek M, Neoral C, Oral I, Jarkovsky J, Dusek L, Indrak K. Papajik T, et al. Among authors: dusek l. Neoplasma. 2008;55(3):215-21. Neoplasma. 2008. PMID: 18348654

6

Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic.

Szotkowski T, Muzik J, Voglova J, Koza V, Maaloufova J, Kozak T, Jarosova M, Michalova K, Zak P, Steinerova K, Vydra J, Lanska M, Katrincsakova B, Sicova K, Pavlik T, Dusek L, Indrak K. Szotkowski T, et al. Among authors: dusek l. Neoplasma. 2010;57(6):578-89. doi: 10.4149/neo_2010_06_578. Neoplasma. 2010. PMID: 20845997

7

Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.

Papajík T, Mysliveček M, Sedová Z, Buriánková E, Procházka V, Koranda P, Raida L, Kubová Z, Palová M, Kučerová L, Flodr P, Jarkovský J, Dušek L, Indrák K. Papajík T, et al. Among authors: dusek l. Eur J Haematol. 2011 Jan;86(1):32-7. doi: 10.1111/j.1600-0609.2010.01532.x. Epub 2010 Nov 11. Eur J Haematol. 2011. PMID: 20874822 Clinical Trial.

8

[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].

Krejcí M, Hájek R, Scudla V, Bacovský J, Indrák K, Faber E, Koza V, Schützová M, Kuca B, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Rezek Z, Praskac P, Cahová S, Vránová M, Veprek K, Januska J, Kessler P, Pozdĕnová V, Walterová L, Stefánek I, Hausdorf P, Meluzínová I, Novosadová L, Lenícková S, Dusek L, Syobodník A, Králová E, Adam Z, Mayer J, Vorlícek J. Krejcí M, et al. Among authors: dusek l. Vnitr Lek. 2001 Sep;47 Suppl 1:40-7. Vnitr Lek. 2001. PMID: 11693062 Clinical Trial. Czech.

9

High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridization.

Jarosová M, Papajík T, Holzerová M, Dusek L, Pikalová Z, Lakomá I, Raida L, Faber E, Divoká M, Vlachová S, Prekopová I, Novosadová A, Pospísilová H, Indrák K. Jarosová M, et al. Among authors: dusek l. Leuk Lymphoma. 2004 Sep;45(9):1835-46. doi: 10.1080/10428190410001683796. Leuk Lymphoma. 2004. PMID: 15223644

10

Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer.

Buchler T, Poprach A, Bortlicek Z, Lakomy R, Chloupková R, Vyzula R, Zemanova M, Kopeckova K, Svoboda M, Slaby O, Kiss I, Studentova H, Hornova J, Fiala O, Kopecky J, Finek J, Dusek L, Melichar B; Czech Metastatic Renal Cancer Cooperative Group. Buchler T, et al. Among authors: dusek l. Clin Genitourin Cancer. 2017 Dec;15(6):e1047-e1053. doi: 10.1016/j.clgc.2017.06.006. Epub 2017 Jun 29. Clin Genitourin Cancer. 2017. PMID: 28720439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters